Neuro rehab research

  • AI neurology market to reach US$2.5bn by 2030

    The AI neurology market will grow from US$705.6m in 2025 to US$2.5bn by 2030, driven by rising neurological disorders. The projected growth represents a compound annual growth rate of 28.9 per cent over the five-year period, as healthcare systems increasingly adopt AI tools for diagnosis and treatment of brain conditions. AI technologies are transforming how [...]

  • Bayer stroke drug sees positive results in clinical trials

    Asundexian reduced recurrent stroke without extra major bleeding in a phase III trial of over 12,300 patients on standard antiplatelets, according to topline results from Bayer. The once-daily oral medicine lowered the risk of repeat strokes in people who had a non-cardioembolic ischaemic stroke or a high-risk transient ischaemic attack (TIA). Non-cardioembolic strokes are not [...]

  • Neurorehab round up

    NR Times explores the latest research developments in the world of neurorehabilitation ​​Brain stimulation improves vision recovery after stroke Hemianopia is a condition that causes loss of half of the visual field (the “vertical midline”), which can happen following stroke and can severely affect daily activities such as reading, driving, or just walking through a [...]

  • Potential treatment could prevent brain damage in premature babies

    A Swedish study reports a potential treatment to prevent premature baby brain damage, using a new prenatal brain model. Researchers observed how cerebral haemorrhages (bleeding in the brain) affect stem cells during preterm birth and successfully tested an antidote that reduced the damage. They identified how neural stem cells in preterm infants are harmed when [...]

  • Drug could significantly slow MND progression, scientists say

    Scientists have discovered a new medicine that they say offers hope of substantially slowing the progress of motor neurone disease (MND). The drug, named M102, works by protecting nerve cells damaged by MND. Preclinical studies of the drug conducted with mice show improvement in movement and nerve function. Researchers are now hopeful the [...]

  • Simple test predicts Parkinson’s risk nine years before diagnosis

    A simple walking test that times how quickly people turn could flag Parkinson's nearly nine years before diagnosis. The finding could help spot patients in the prodromal phase – the earliest stage when brain damage starts but symptoms are subtle. This window can last years before tremor and movement problems prompt diagnosis. The [...]

  • $1.75m joint venture to accelerate breakthrough tech for neurological conditions

    A new $1.75 million joint venture will fund and scale breakthrough technologies designed to transform the lives of people living with neurological conditions. The programme, a collaboration between Australian disability services provider MSWA and Founders Factory, will back and fast-track global startups developing cutting-edge solutions, including the use of AI, robotics and wearables that address [...]

  • Heavy alcohol use linked to brain bleed in later life

    People who drink heavily are more likely to suffer severe brain bleeds at a younger age, with larger haemorrhages occurring about a decade earlier than in non-drinkers, new research has revealed. Patients who consumed three or more alcoholic drinks a day experienced brain bleeds at an average age of 64, compared with 75 for non-drinkers, [...]

  • National Rehabilitation Centre to be a ‘beacon of hope’ for patients

    The country’s first NHS National Rehabilitation Centre (NRC) is set to open its doors for patients. The NRC is a 70-bed, state-of-the-art specialist rehab centre for NHS patients who have experienced a life-changing illness or injury. The centre, at Stanford Hall in Nottinghamshire, is run and staffed by Nottingham University Hospitals NHS Trust (NUH). [...]

  • People with spinal cord injuries more likely to develop chronic disorders

    People with traumatic spinal cord injuries face a higher risk of developing long-term health conditions, regardless of their age, injury location or previous health status, new research has found. Researchers found that patients with traumatic spinal cord injuries (TSCI) were more likely to develop cardiovascular, endocrine, neurological and psychiatric disorders than people without such injuries. [...]